Showing results (241-250 of 2,105) with videos related to
Sort By:
Pageof 211
CNS Drugs|May 25, 2007
Oral disease-modifying treatments for multiple sclerosis: the story so farBernd C Kieseier, Heinz WiendlCNS Drugs|January 16, 2023
Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the LiteratureSenta Frol, Mišo Šabovič, Janja Pretnar OblakCNS Drugs|December 21, 2022
Treatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysisMubeen Janmohamed, Haris Hakeem, Suyi Ooi, et al.CNS Drugs|November 27, 2019
Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum DisorderRichard Houghton, Frank de Vries, Georg LossCNS Drugs|November 5, 2019
The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in EpilepsyNatasha Ivanova, Jana TchekalarovaCNS Drugs|November 6, 2019
Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A ReviewErin Kelty, David B PreenCNS Drugs|January 12, 2019
Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and ManagementThomas Rego, Sarah Farrand, Anita M Y Goh, et al.CNS Drugs|July 20, 2021
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort StudyVera M Ludwig, Cathrin Sauer, Allan H Young, et al.CNS Drugs|July 20, 2021
Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series StudyLe Gao, Kenneth K C Man, Esther W Chan, et al.CNS Drugs|July 5, 2021
Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for PharmacotherapyEthan S BursteinPageof 211